120
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Bladder Dysfunction in Iranian Patients with Multiple Sclerosis

ORCID Icon, ORCID Icon, , , &
Pages 345-349 | Published online: 02 Apr 2020

References

  • Ghajarzadeh M, Jalilian R, SAhraian MA, et al. Pain in patients with multiple sclerosis. Maedica. 2018;13(2):125.
  • Jongen PJ, Blok BF, Heesakkers JP, Heerings M, Lemmens WA, Donders R. Validation of a dutch version of the actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis: an observational web-based study. Health Qual Life Outcomes. 2015;13(1):175. doi:10.1186/s12955-015-0368-4
  • Ghajarzadeh M, Azizi S, Moghadasi AN, et al. Validity and reliability of the persian version of the perception de la scle’rose en plaques et de ses pousse’es questionnaire evaluating multiple sclerosis-related quality of life. Int J Prev Med. 2016;7.
  • Askari F, Ghajarzadeh M, Mohammadifar M, Azimi A, Sahraian MA, Owji M. Anxiety in patients with multiple sclerosis: association with disability, depression, disease type and sex. Acta Med Iran. 2014;889–892.
  • Ghajarzadeh M, Jalilian R, Mohammadifar M, Sahraian MA, Azimi A. Sexual function in women with multiple sclerosis. Acta Med Iran. 2014;315–318.
  • Ghajarzadeh M, Sahraian MA, Fateh R, Daneshmand A. Fatigue, depression and sleep disturbances in Iranian patients with multiple sclerosis. Acta Med Iran. 2012;244–249.
  • Vitkova M, Rosenberger J, Krokavcova M, et al. Health-related quality of life in multiple sclerosis patients with bladder, bowel and sexual dysfunction. Disabil Rehabil. 2014;36(12):987–992. doi:10.3109/09638288.2013.825332
  • Nortvedt M, Riise T, Myhr K, Landtblom A-M, Bakke A, Nyland H. Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Multiple Sclerosis J. 2001;7(4):231–235. doi:10.1177/135245850100700404
  • Chancellor M, Blaivas J. Urological and sexual problems in multiple sclerosis. Clin neurosci. 1994;2(3–4):189–195.
  • Tang DH, Colayco D, Piercy J, Patel V, Globe D, Chancellor MB. Impact of urinary incontinence on health-related quality of life, daily activities, and healthcare resource utilization in patients with neurogenic detrusor overactivity. BMC Neurol. 2014;14(1):74. doi:10.1186/1471-2377-14-74
  • Ukkonen M, Elovaara I, Dastidar P, Tammela T. Urodynamic findings in primary progressive multiple sclerosis are associated with increased volumes of plaques and atrophy in the central nervous system. Acta Neurol Scand. 2004;109(2):100–105. doi:10.1034/j.1600-0404.2003.00184.x
  • Goldstein I, Siroky MB, Sax DS, Krane RJ. Neurourologic abnormalities in multiple sclerosis. J Urol. 1982;128(3):541–545. doi:10.1016/S0022-5347(17)53037-2
  • Petersen T, Pedersen E. Neurourodynamic evaluation of voiding dysfunction in multiple sclerosis. Acta Neurol Scand. 1984;69(6):402–411. doi:10.1111/ane.1984.69.issue-6
  • Azadvari M, Naser Moghadasi A, Azimi A, et al. Persian adaptation of actionable bladder symptom screening tool among patients with multiple sclerosis. J Multidiscip Healthc. 2020;13:79.
  • Nakipoglu G, Kaya A, Orhan G, et al. Urinary dysfunction in multiple sclerosis. J Clin Neurosci. 2009;16(10):1321–1324. doi:10.1016/j.jocn.2008.12.012
  • Akkoc Y, Ersoz M, Yuceyar N, et al. Overactive bladder symptoms in patients with multiple sclerosis: frequency, severity, diagnosis and treatment. J Spinal Cord Med. 2016;39(2):229–233. doi:10.1179/2045772315Y.0000000021
  • Hennessey A, Robertson N, Swingler R, Compston D. Urinary, faecal and sexual dysfunction in patients with multiple sclerosis. J Neurol. 1999;246(11):1027–1032. doi:10.1007/s004150050508
  • Zecca C, Riccitelli G, Disanto G, et al. Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients’ quality of life. Eur J Neurol. 2016;23(7):1228–1234. doi:10.1111/ene.2016.23.issue-7
  • Mahajan ST, Patel PB, Marrie RA. Under treatment of overactive bladder symptoms in patients with multiple sclerosis: an ancillary analysis of the NARCOMS patient registry. J Urol. 2010;183(4):1432–1437. doi:10.1016/j.juro.2009.12.029
  • Phe V, Chartier–Kastler E, Panicker JN. Management of neurogenic bladder in patients with multiple sclerosis. Nat Rev Urol. 2016;13(5):275. doi:10.1038/nrurol.2016.53
  • Gallien P, Robineau S, Nicolas B, Le Bot M-P, Brissot R, Verin M. Vesicourethral dysfunction and urodynamic findings in multiple sclerosis: a study of 149 cases. Arch Phys Med Rehabil. 1998;79(3):255–257. doi:10.1016/S0003-9993(98)90003-X
  • Miller A, Lublin F, Coyle PK. Multiple Sclerosis in Clinical Practice. CRC Press; 2003.
  • Kasabian NG, Krause I, Brown WE, Khan Z, Nagler HM. Fate of the upper urinary tract in multiple sclerosis. Neurourol Urodyn. 1995;14(1):81–85.
  • Amarenco G, Kerdraon J, Denys P. Bladder and sphincter disorders in multiple sclerosis clinical, urodynamic and neurophysiological study of 225 cases. Revue neurologique. 1995;151(12):722–730.
  • Wheeler JS Jr, Siroky MB, Pavlakis AJ, Goldstein I, Krane RJ. The changing neurourologic pattern of multiple sclerosis. J Urol. 1983;130(6):1123–1125. doi:10.1016/S0022-5347(17)51716-4
  • De Sèze M, Ruffion A, Denys P, Joseph P-A, Perrouin-Verbe B, group IFN-Ues. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Multiple Sclerosis J. 2007;13(7):915–928. doi:10.1177/1352458506075651
  • Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub‐committee of the international continence society. Neurourol Urodynamics. 2002;21(2):167–178.
  • Hosseinzadeh A, Baneshi MR, Sedighi B, Kermanchi J, Haghdoost AA. Incidence of multiple sclerosis in Iran: a nationwide, population-based study. Public Health. 2019;175:138–144. doi:10.1016/j.puhe.2019.07.013
  • Mohebi F, Eskandarieh S, Mansournia MA, Mohajer B, Sahraian MA. Multiple sclerosis in Tehran: rising prevalence alongside stabilizing incidence - true increase or enhanced diagnosis? Arch Iran Med. 2019;22(8):429–434.